FDA 483 - Cerovene Inc. - April 28, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Cerovene Inc., a contract drug manufacturer in Valley Cottage, NY, revealed significant deficiencies in equipment cleaning and maintenance, production and process controls, and computer system controls. Observations included caked residue on "clean" equipment, inadequate cleaning procedures lacking defined parameters, and unvalidated hand cleaning processes. Additionally, the firm failed to review data, audit trails, and alarm reports from critical equipment, and allowed shared "admin" logins, indicating a risk to drug product quality and integrity.
ID · 184d7a73-cf0a-4331-9574-441718afd839